LAMP2 and COVID-19: Using a plasma from COVID-19 patients that is known to contain anti-Spike and anti-Nucleocapsid antibodies (72), we detected Spike in Lamp2-containing lysosomes (Fig. 8A), which we previously established to be the primary site of Spike protein trafficking in human cells (72).